investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
Brett Stewart Carver
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Levi A. Garraway
Systematic Genetic Characterization of African American Prostate Cancer
Prostate
Pathology
Karin Alexandra Skalina
Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity
Prostate
William Figg
Clinical Pharmacogenetics
Prostate
Pathology
Peter S. Nelson
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer
Prostate
Xianglin Tan
Repurposing Metformin and Aspirin for Prostate Cancer Prevention and Control
Prostate
William Isaacs
Identifying Prostate Cancer Genes
Prostate
Pathology
Joshi J Alumkal
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
Prostate
Pathology
Theresa A Guise
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
Prostate
Antonio Fojo
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
Prostate